Grantham, Mayo, Van Otterloo & Co (GMO)’s Amedisys AMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-164,064
| Closed | -$15.2M | – | 607 |
|
|
2025
Q1 | $15.2M | Buy |
+164,064
| New | +$15.2M | 0.05% | 204 |
|
|
2024
Q4 | – | Sell |
-141,521
| Closed | -$13.7M | – | 573 |
|
|
2024
Q3 | $13.7M | Buy |
+141,521
| New | +$13.7M | 0.04% | 237 |
|
|
2023
Q4 | – | Sell |
-314,914
| Closed | -$29.4M | – | 490 |
|
|
2023
Q3 | $29.4M | Buy |
314,914
+215,233
| +216% | +$20.1M | 0.14% | 136 |
|
|
2023
Q2 | $9.11M | Buy |
+99,681
| New | +$9.11M | 0.04% | 267 |
|
|
2020
Q2 | – | Sell |
-7,300
| Closed | -$1.34M | – | 745 |
|
|
2020
Q1 | $1.34M | Buy |
+7,300
| New | +$1.34M | 0.01% | 456 |
|